CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
- 14 December 2009
- journal article
- review article
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 21 (1), 41-48
- https://doi.org/10.1016/j.cytogfr.2009.11.009
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in BoneCancer Research, 2009
- Prostate cancer promotes CD11b positive cells to differentiate into osteoclastsJournal of Cellular Biochemistry, 2009
- CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulationJournal of Biological Chemistry, 2008
- The evolving biology and treatment of prostate cancerJournal of Clinical Investigation, 2007
- Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastasesBMC Cancer, 2007
- Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing hostBlood, 2007
- Chemokines in multiple myelomaExperimental Hematology, 2006
- CCL2 is a Potent Regulator of Prostate Cancer Cell Migration and ProliferationNeoplasia, 2006
- Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapyEuropean Journal Of Cancer, 2006
- Monocyte Chemoattractant Protein-1 Expression by Osteoblasts Following Infection withStaphylococcus aureusorSalmonellaJournal of Interferon & Cytokine Research, 2001